StopDown
Funding · 25 February 2026ZeroHarm Sciences₹65 crorePlant-based nutraceutical supplements

ZeroHarm Sciences raises ₹65 crore Series A

By · Editor ·

Series AHyderabadFounded 2020
  • ZeroHarm Sciences makes 100% plant-based health supplements using nano-formulation technology
  • It raised ₹65 crore ($7.2 million) in Series A funding led by Kotak Alternate Asset Managers
  • The company plans to build a health platform and expand internationally to the US, UK, and Middle East

What happened

  • ZeroHarm Sciences raised ₹65 crore in Series A funding.
  • The round was led by Kotak Alternate Asset Managers Limited via its Kotak Life Sciences Fund I, which invested ₹40 crore.
  • Alkemi Growth Capital, a healthcare and consumer wellness-focused venture fund, participated with ₹25 crore.
  • The company will use the funds to build a 'Trust over Promise' health platform that demonstrates supplement efficacy through measurable consumer health outcomes.
  • Funds will also go toward national brand building and international expansion into the USA, UK, and Middle East.
  • ZeroHarm Sciences also plans to scale its vertically integrated R&D and manufacturing ecosystem.
  • Cipher-Plexus acted as the exclusive financial advisor for the transaction.

Why it matters

  • India's nutraceutical market is projected to reach $18 billion by 2025.
  • The global nutraceutical market is expected to cross $720 billion by 2027.
  • Recent fundraises in the space include Elevate Now (₹18 crore) and Earthful (₹26 crore).
  • The company's proprietary nano-formulation technology differentiates it from competitors like Kapiva, Plix, HealthKart, and Wellbeing Nutrition.

The business

  • ZeroHarm Sciences is a Hyderabad-based vertically integrated nutraceutical company.
  • It develops 100% plant-based health supplements using proprietary nano-formulation technology.
  • The technology converts plant-derived nutrients into nano-sized particles to enhance bioavailability and enable controlled release at lower dosages.
  • The company works with a network of over 10,000 farmers across Northeast India and the Himalayan region for medicinal plant sourcing.
  • It controls the full value chain from cultivation to nano-processing.
  • ZeroHarm Sciences has filed and received patents for multiple nano formulations, including turmeric-based phytochemicals, iron folic acid combinations, carotenoid-based eye health solutions, and synbiotic gut health compositions.
  • Its portfolio includes over 60 SKUs across categories such as diabetes management, heart health, joint care, immunity, gut health, oncology support, women's wellness, and performance nutrition.
  • Products are sold through its own website, Amazon, Flipkart, and quick commerce platforms.
  • The company has served over 300,000 customers (3 lakh).

The founders

Sachin Darbarwar

Co-founder and CEO
  • Co-founder and CEO of ZeroHarm Sciences.

Shweta Darbarwar

Co-founder
  • Co-founder of ZeroHarm Sciences.

Who put in money

  • Kotak Alternate Asset Managers Limited lead — Manages the Kotak Life Sciences Fund I, which invested ₹40 crore in this round.
  • Alkemi Growth Capital participated — Healthcare and consumer wellness-focused venture fund that invested ₹25 crore.

In numbers

₹65 croreFunding raised · 2026
300,000Customers served · 2026
60+SKUs in portfolio · 2026
10,000+Farmer network · 2026

What happens next

  • Build a 'Trust over Promise' health platform demonstrating supplement efficacy through measurable consumer health outcomes.
  • Expand nationally with brand building initiatives.
  • Enter international markets including the USA, UK, and Middle East.
  • Scale the vertically integrated R&D and manufacturing ecosystem.

Up against

KapivaPlixHealthKartWellbeing Nutrition

Words to know

nano-formulation
A process that breaks down nutrients into extremely tiny particles (nanometers) to improve how well the body absorbs them.
nutraceutical
A food or supplement that provides health benefits, such as vitamins, minerals, or herbal extracts.
SKU
Stock Keeping Unit – a unique identifier for each product variant, used to track inventory.
bioavailability
The proportion of a nutrient that enters the bloodstream and can be used by the body.

The numbers around it

Healthcare & Life Sciences in February 2026: 18 rounds with a disclosed amount, $66.5 million in all; the biggest was Pandorum Technologies ($18M). Every sector this year →

Other articles talking about it

Read it as a card in the app

Terms in this story

  • Funding stage: Startups raise money in steps called funding stages: pre-seed, seed, Series A, B, C and later, ending in a listing or a sale. Each step is larger and asks for more proof. In India, Series A rounds run from a few million dollars to about $15 million, as of November 2026.
  • Series A: Series A is usually the first large round a startup raises from venture capital funds, after it has shown that people want what it sells. In India it commonly runs from a few million dollars to about $15 million, or roughly ₹25 crore to over ₹100 crore, with founders selling about 15 to 25 percent, as of November 2026.
  • Lead investor: A lead investor is the investor that sets the price and main terms of a funding round, does the deepest checks on the company and usually puts in the largest cheque. When a headline says a round was led by a fund, that fund was the first to commit and shaped the deal that others joined.

Everything on ZeroHarm Sciences → · All startup news on 25 February 2026 →

Is this ZeroHarm Sciences? Get your “Featured on StopDown” badge →